Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:56:30.151Z.
Calculation as of: 2026-10-06T14:56:30.151Z.
Quote observation: 2026-10-06T14:55:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80308b770ced1bdfd1e00e86669fc95a739831df2c659c0b91f47c7a41a76c0c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$172.77M
Free Cash Flow Yield
N/A
TTM Avg
12.80%
3Y Avg
12.80%
5Y Avg
12.80%
Market Cap
$172.18M
Free Cash Flow Yield
N/A
TTM Avg
0.25%
3Y Avg
0.25%
5Y Avg
0.25%
Market Cap
$177.78M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.41M
Free Cash Flow Yield
10.84%
TTM Avg
9.84%
3Y Avg
5.75%
5Y Avg
5.19%
Market Cap
$179.09M
Free Cash Flow Yield
N/A
TTM Avg
7.28%
3Y Avg
8.72%
5Y Avg
8.72%
Market Cap
$168.56M
Free Cash Flow Yield
12.36%
TTM Avg
7.35%
3Y Avg
3.01%
5Y Avg
3.15%
Market Cap
$180.85M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.89M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.77M | N/A | 12.80% | 12.80% | 12.80% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.18M | N/A | 0.25% | 0.25% | 0.25% |
| Nkarta, Inc. (NKTX)vs › | $172.07M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.78M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $169.41M | 10.84% | 9.84% | 5.75% | 5.19% |
| Journey Medical Corporation (DERM)vs › | $179.09M | N/A | 7.28% | 8.72% | 8.72% |
| Organogenesis Holdings Inc. (ORGO)vs › | $168.56M | 12.36% | 7.35% | 3.01% | 3.15% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.85M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | N/A | 0.52% | 0.52% | 7.43% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
